| Name |
paired box 9 |
EYA transcriptional coactivator and phosphatase 2 |
| Structure |
No pdb structure
|
|
| GO Annotations |
Cellular Component |
|
|
| Molecular Function |
|
|
| Biological Process |
|
|
| Pathways |
None
|
|
| Diseases |
|
None
|
| GWAS |
|
- A body shape index ( 34021172
)
- Allergic disease (asthma, hay fever and/or eczema) (age of onset) ( 32603359
)
- Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis) ( 32603359
)
- Allergic rhinitis ( 31361310
)
- Asthma ( 32296059
)
- Body fat percentage and triglycerides (pairwise) ( 33619380
)
- Brain volume in infants (intracranial brain volume) ( 28763065
)
- Coffee consumption ( 31046077
)
- Fasting insulin ( 34059833
)
- FEV1 ( 30804560
)
- Glaucoma (primary open-angle) ( 33627673
)
- Heel bone mineral density ( 28869591
30598549
)
- High light scatter reticulocyte count ( 32888494
)
- High light scatter reticulocyte percentage of red cells ( 32888494
)
- Hip circumference adjusted for BMI ( 34021172
)
- Hip index ( 34021172
)
- Liver enzyme levels (alanine transaminase) ( 33972514
)
- Lung function (FVC) ( 30804560
30061609
)
- Non-del(5q) myelodysplastic syndromes ( 31738830
)
- Peak expiratory flow ( 30804560
)
- Reticulocyte count ( 32888494
)
- Thiazide-induced adverse metabolic effects in hypertensive patients ( 23400010
)
- Triglyceride levels ( 32154731
32203549
)
- Triglyceride levels in current drinkers ( 30698716
)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716
)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716
)
- Type 2 diabetes ( 30054458
30297969
)
- Visceral adipose tissue/subcutaneous adipose tissue ratio ( 22589738
)
- Waist circumference adjusted for body mass index ( 34021172
)
- Waist-hip index ( 34021172
)
- Waist-to-hip ratio adjusted for BMI ( 26426971
34021172
)
- Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) ( 28443625
)
- Waist-to-hip ratio adjusted for BMI (age <50) ( 26426971
)
- Waist-to-hip ratio adjusted for BMI (age >50) ( 26426971
)
- Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) ( 28448500
)
- Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) ( 28443625
)
- Waist-to-hip ratio adjusted for BMI in active individuals ( 28448500
)
- Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) ( 26426971
)
- Waist-to-hip ratio adjusted for body mass index ( 28448500
25673412
)
|
| Interacting Genes |
25 interacting genes:
EYA2
FUBP3
GTF2A1L
KDM5B
KLF4
KRTAP13-3
LMO2
MSX1
MYLIP
NR0B2
PFDN5
PLAGL2
SFN
SLAIN1
SSX4
TEPSIN
TLE1
TLE2
TRIP13
TRIP4
VPS37C
WWOX
ZNF343
ZNF440
ZNF580
|
36 interacting genes:
AATK
ATOSB
BAG3
CATSPER1
CDK18
DMRTB1
DTX2
DUSP21
ENKD1
FBXO7
GNAI2
GNAZ
HGS
IQUB
LGALS4
MED25
PATZ1
PAX9
PIN1
POGZ
RBPMS
RFX2
ROR2
SIX1
SIX4
SNRPC
SPG21
SUOX
TEKT4
TEKT5
TFG
TLE5
TRAF4
TRAPPC6A
TSSK3
VPS37C
|
| Entrez ID |
5083 |
2139 |
| HPRD ID |
01336
|
09041
|
| Ensembl ID |
ENSG00000198807
|
ENSG00000064655
|
| Uniprot IDs |
P55771
Q2L4T1
|
E7ETN2
O00167
|
| PDB IDs |
Not available
|
3GEB
3HB0
3HB1
4EGC
5ZMA
7F8G
7F8H
|
| GO Terms Enriched among Interactors |
|
|